Intuitive Surgical board approves 3-for-1 stock split

Intuitive Surgical (NSDQ:ISRG) said today that its board of directors approved a 3-for-1 split of the company’s common stock The stock split is still subject to shareholder approval, the Sunnyvale, Calif.-based company said, with a special meeting of stockholders slated for September 22. With the split, each Intuitive shareholder would receive 2 additional shares for every share […]

Study: Esophageal surgeries with robotic platforms safe and effective

Transchiatal esophagectomy procedures utilizing robotic platforms are “effective and safe” for carefully selected patients, according to a new study from Allina Health hospitals. The robotic technology platforms can provide operating surgeons with better views during surgery and allow lymph nodes to be removed without additional incisions, according to the study. Results from the study, which […]

Dentsply Sirona shares steady despite Q2 sales miss

Shares in Dentsply Sirona (NSDQ:XRAY) have fallen slightly today after the medical device maker met earnings per share expectations but missed sales consensus on Wall Street with its 2nd quarter earnings report. The York, Penn.-based company posted losses of $1.1 billion, or $4.58 per share on sales of $992.7 million for the 3 months ended June 30, seeing […] +5 | The top 5 medtech stories for August 11, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in […]

7 medtech stories we missed this week: August 11, 2017

[Image from] From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its […]

Renovis wins FDA nod for Tesera lumbar interbody fusion systems

Renovis Surgical Technologies said today it won FDA 510(k) clearance for its Tesera lumbar porous titanium interbody fusion systems. The Redlands, Calif.-based company said its newly cleared Tesera devices feature implants designed for direct posterior or transforaminal approaches, and includes straight and curved options in multiple heights, widths and lengths. The Tesera devices are produced […]

SteadyMed tops Q2 sales, EPS estimates

Shares in SteadyMed (NSDQ:STDY) fell today after the pharmaceutical company beat sales expectations on Wall Street with its second quarter results, but missed EPS estimates. The San Ramon, Calif.-based company posted a net loss of -$8.1 million on sales of $319,000 for the 3 months ended June 30, for bottom-line loss of -14% on sales growth of […]

Pediatric ear tube delivery system dev Preceptis seeks $1m in funding

Pediatric ear tube delivery device developer Preceptis Medical is looking to raise $1 million, according to an SEC filing posted this week. The Plymouth, Minn.-based company produces the Hummingbrid TTS tympanostomy tube system designed to reduce pain for pediatric patients undergoing ear tube procedures. T he device won FDA clearance last July for use with […]

Trump declares national emergency over opioid epidemic

President Trump said yesterday that he is preparing to declare the opioid epidemic a national emergency. This is a reversal from an announcement made earlier this week by Health and Human Services Secretary Tom Price, who said that they would not declare a state of emergency. “The opioid crisis is an emergency, and I’m saying […]

Cytori Therapeutics posts mixed Q2

Shares in Cytori Therapeutics (NSDQ:CYTX) fell today after the biotech missed sales expectations on Wall Street with its second quarter results, but topped EPS estimates. The San Diego, Calif.-based company posted a net loss of -$6 million on sales of $1.5 million for the 3 months ended June 30, for bottom-line growth of 6% on sales loss […]